Welcome to our dedicated page for Singular Genomics Systems news (Ticker: OMIC), a resource for investors and traders seeking the latest updates and insights on Singular Genomics Systems stock.
Singular Genomics Systems, Inc. (OMIC) drives innovation in next-generation sequencing and multiomics technologies, empowering researchers and clinicians worldwide. This dedicated news hub provides investors and industry professionals with essential updates on the company's scientific advancements and market developments.
Access real-time information about OMIC's sequencing platform innovations, strategic partnerships, and regulatory milestones. Our curated collection includes earnings reports, product launch announcements, and research collaborations - all critical for understanding the company's position in the competitive genomics sector.
Key updates cover commercial deployments of the G4 sequencing system, spatial biology breakthroughs, and leadership changes impacting OMIC's growth trajectory. Bookmark this page for streamlined tracking of operational developments that shape precision medicine and life science research.
Singular Genomics Systems (Nasdaq: OMIC) will present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida. The presentation is scheduled for Wednesday, June 12, 2024, at 7:40 a.m. PT / 10:40 a.m. ET. Management will participate in a fireside chat, and a live and recorded webcast will be available at investor.singulargenomics.com. Singular Genomics leverages novel next-generation sequencing (NGS) and spatial multiomics technologies to support researchers and clinicians.
Singular Genomics (Nasdaq: OMIC) reported its Q1 2024 financial results and highlighted recent achievements. Revenue for the quarter stood at $0.4 million, primarily from one G4 instrument sale and consumables. The company shipped six G4 systems, totaling 30 commercial units. Gross profit was negative $0.4 million, and operating expenses were $26.4 million, leading to a net loss of $25.0 million ($0.34 per share). Singular Genomics aims to launch its G4X spatial sequencer in 2025 and continues to support its existing customer base and expand its spatial services.
Singular Genomics Systems, Inc. (Nasdaq: OMIC) will announce its first quarter 2024 financial results on May 14, 2024, after the market closes. The company focuses on next-generation sequencing and spatial multiomics technologies. The management will host a conference call to discuss the results. Investors can join the call or access the webcast on investor.singulargenomics.com.
FAQ
What is the current stock price of Singular Genomics Systems (OMIC)?
What is the market cap of Singular Genomics Systems (OMIC)?
